Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Dice Therapeutics, Inc. (DICE)  
$47.55 0.00 (0.00%) as of 4:30 Tue 8/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 54,759,000
Market Cap: 2.60(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $30.03 - $47.55
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   DICE Therapeutics is a a biopharmaceutical company using its proprietary technology platform, DELSCAPE, to build a pipeline of oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DELSCAPE is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs). Co.'s lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in immunology indications. Co. is also developing oral therapeutic for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 2,647,701
Total Buy Value $0 $0 $0 $88,116,065
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 7
Total Shares Sold 0 0 2,638,166 2,666,152
Total Sell Value $0 $0 $121,279,876 $122,111,370
Total People Sold 0 0 6 7
Total Sell Transactions 0 0 6 10
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 12
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Rubin Michael P. 10% Owner   –       –       •   2021-09-17 4 B $17.00 $3,995,000 I/I 235,000 3,292,871 1.5 -57%     
   Rubin Michael P. 10% Owner   –       –       •   2021-09-17 4 A $0.00 $0 I/I 3,057,871 3,057,871     -
   Shah Rajeev M. Director   –       •       •   2021-09-17 4 B $17.00 $23,800,000 I/I 1,400,000 786,407 2.25 -57%     
   Shah Rajeev M. Director   –       •       •   2021-09-17 4 A $0.00 $0 I/I 3,808,911 708,829     -
   Scopa James Paul Director   –       •      –    2021-09-15 4 B $17.00 $102,000 D/D 6,000 55,841 2.39     -
   Scopa James Paul Director   –       •      –    2021-09-14 3 IO $0.00 $0 D/D 0 69,000     -
   Robertson Scott M. CFO & CBOOfficer   •       –      –    2021-09-14 3 IO $0.00 $0 D/D 0 284,600     -
   Tetlow Sharon Director   –       •      –    2021-09-14 3 IO $0.00 $0 D/D 0 69,000     -
   Judice Kevin CEOOfficer   •       •      –    2021-09-14 3 IO $0.00 $0 D/D 0 971,644     -
   Scheller Richard H Director   –       •      –    2021-09-14 3 IO $0.00 $0 D/D 0 113,000     -
   Jacobsen John R. CSOOfficer   •       –      –    2021-09-14 3 IO $0.00 $0 D/D 0 231,625     -
   Timothy Lu CMOOfficer   •       –      –    2021-09-14 3 IO $0.00 $0 D/D 0 215,835     -

  12 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed